Nucleix: Nucleix Earns FDA Nod for Non-Muscle Invasive Bladder Cancer Monitoring
Bladder EpiCheck it a sensitive, specific test to analyze subtle, disease-specific changes across 15 methylation markers associated with bladder cancer.
Read full article »
Nucleix is an Israel-based liquid biopsy company that develops and supplies cancer screening and detection solutions for the healthcare industry.
Read more